Article History
First Online: 2 January 2019
Compliance with Ethical Standards
:
: No funding was received for the preparation of this review.
: Jonas Graf received travel/meeting/accommodation reimbursements from Biogen, and Merck Serono. Orhan Aktas received, with approval of the Rector of Heinrich-Heine-University, grants from the German Research Foundation (DFG) and the German Ministry for Education and Research (BMBF) as part of the German Competence Network Multiple Sclerosis (Kompetenznetz Multiple Sklerose (KKNMS); for NEMOS (Neuromyelitis optica Studiengruppe, German Neuromyelitis Optica Study group) NationNMO-PAT FKZ 01GI1602B), the Eugène Devic European Network (EU-FP7), and honoraria and travel/accommodation/meeting expenses from Almirall, Bayer, Biogen, Medimmune, Merck Serono, Novartis, Roche, Sanofi-Genzyme, and Teva. Konrad Rejdak has no conflicts of interest to declare. Hans-Peter Hartung received, with approval of the Rector of Heinrich-Heine-University and the CEO of University of Düsseldorf Hospital, honoraria for consulting, serving on steering committees, and speaking from Biogen, CSL Behring, Geneuro, Genzyme, LFB, Medimmune, Merck, Novartis, Octapharma, Opexa, Receptos/Celgene, Roche, Sanofi, and Teva.